FTC Eyes Drugmaker Rebates Boosting Higher Cost Drugs
Bolstered by a newly full roster, the Federal Trade Commission teed up one of its most ambitious open meetings in months Thursday that includes a plan to issue a new policy...To view the full article, register now.
Already a subscriber? Click here to view full article